Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Peritoneal Neoplasms × birinapant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1

Interventions

Cisplatin 5 Paclitaxel 4 Fluorouracil 3 sodium thiosulfate 2 Cytoreduction Surgical Procedures 2 veliparib 1 vandetanib 1 nilotinib 1 birinapant 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiation 1 Oxaliplatin 1 Mitomycin 1 Doxorubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01681368 2017-05-30

Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated

11 enrolled 19 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡